Full-spectrum healthcare counsel for physicians, provider groups, platforms, operators, and the investors behind them — regulatory, transactional, operational, labor, reimbursement, real estate, and enforcement matters across the Florida healthcare delivery system.
Yazen "Yaz" Dides is a healthcare attorney whose practice spans the full breadth of healthcare law — regulatory compliance, corporate and transactional matters, tax structuring, day-to-day operations, labor and employment, reimbursement and managed care, digital health, real estate, and government investigations.
The practice is designed to function as outside general counsel for healthcare clients — covering the regulatory perimeter (Stark Law, the Anti-Kickback Statute, the False Claims Act, HIPAA, Medicare and Medicaid billing, Florida's corporate practice of medicine doctrine, AHCA and DOH licensure, HCCA reporting obligations, state fee-splitting prohibitions, and FDA-LDT guidance), the transactional lifecycle (formation through exit), the commercial infrastructure (employment, contracting, policies, payor relations), and the risk framework (audits, investigations, enforcement defense) that together define the regulated healthcare industry.
AHCA licensure, CPOM enforcement risk, HCCA assignments, the MSO/PC friendly-PC structure Florida regulators have gotten more sophisticated about — that's the daily water I swim in.
Yaz represents private equity funds and investors, physician groups and platforms, health and wellness companies, MSOs and management organizations, IPAs and clinically integrated networks, ambulatory surgery centers, DSOs and dental platforms, behavioral health providers, DMEPOS companies, hospitals and health systems, urgent care operators, direct primary care practices, and healthcare nonprofits. He has led or co-led transactions exceeding hundreds of millions of dollars in aggregate deal volume — guiding clients through the full M&A lifecycle from letter of intent and due diligence through definitive agreements, closing, and post-closing integration, on both sell-side and buy-side engagements. That experience extends across the investor side of physician platform deals and the operator side of health-tech and DTC lab models.
A dual background in corporate and tax law informs his approach to deal structuring, recapitalizations, equity rollovers, and reorganizations — providing integrated counsel that aligns regulatory compliance with strategic business objectives and tax efficiency.
Recent engagements include serving as lead regulatory and transactional counsel to a national hybrid telehealth and wellness platform — architecting the multi-entity corporate structure, conducting eleven comprehensive fifty-state regulatory surveys across DTC testing, CPOM, fee-splitting, licensing, and kickback law, securing physician licensing across more than forty-five states via the Interstate Medical Licensure Compact, negotiating the full suite of launch-phase agreements (vendor MSAs, professional services contracts, HIPAA-compliant NDAs, pathology lab agreements), and mitigating AKS, CPOM, and FDA-LDT risk in light of recent jurisprudence under Loper Bright.
Beyond discrete engagements, the practice operates as outside general counsel to select healthcare operators — covering day-to-day legal questions with the continuity, commercial fluency, and responsiveness that in-house counsel would bring. Based in Sarasota and serving clients across Florida, with engagements nationwide where deep Florida healthcare regulatory fluency is required.
The practice spans every dimension of healthcare law — from the regulatory framework that governs the industry and the transactions that reshape it, through the day-to-day operational, labor, and reimbursement matters that keep healthcare businesses running, to the investigations and enforcement actions they sometimes face. Eight practice families, each addressing a distinct layer of a regulated industry.
The firm represents the full range of healthcare operators, investors, and providers — from solo physicians and physician groups to PE-backed platforms and hospital systems. Each sector brings its own regulatory framework, transactional conventions, and operating cadence.
Solo practitioners, specialty groups, and multi-site practices. Employment, formation, transactions, and day-to-day counsel.
PE funds and healthcare-focused investors. Platform acquisitions, portfolio company support, and regulatory diligence.
Management services organizations, multi-state platforms, and friendly-PC architectures across specialties.
Independent practice associations, ACOs, and clinically integrated networks. Formation, governance, and payor contracting.
ASC formation, joint ventures, physician syndication, and licensure. Stark-compliant ownership and operational structuring.
Dental service organizations and dental practice platforms. CPOM-compliant structures across multi-state footprints.
Behavioral and mental health providers, substance use disorder facilities, and telepsychiatry platforms.
Durable medical equipment, prosthetics, orthotics, and supplies companies. Medicare enrollment, accreditation, and compliance.
Acute care hospitals, specialty hospitals, and integrated health systems. Strategic transactions and operational counsel.
Urgent care operators and multi-site networks. Licensure, lease structuring, physician staffing, and transactional support.
DPC practices and membership-based primary care models. Subscription structures, Florida regulatory framework, and scaling.
501(c)(3) healthcare organizations, community health providers, and tax-exempt health entities. Governance and tax-exempt compliance.
Representative matters listed reflect engagements across the attorney's practice, including work performed by Yazen Dides during his tenure at prior firms (Fox Rothschild LLP; Blalock Walters, P.A.) as well as engagements of the Law Office of Yazen Dides. Client names, specific deal values, and identifying details are withheld to preserve confidentiality. Case results depend on a variety of factors unique to each matter. Prior results do not guarantee or predict a similar outcome with respect to any future matter. Engagement details are available upon request subject to applicable confidentiality obligations.
How federal fraud-and-abuse law and Florida's corporate practice of medicine doctrine interact in the design of MSO platforms, physician compensation, and referral relationships.
A practical framework for reviewing and updating physician restrictive covenants under Fla. Stat. § 542.335 in light of federal rulemaking and judicial challenges.
Buyer-side and seller-side rider language for AI-enabled clinical tools, including diligence checklists, indemnity carve-outs, and RWI-aligned representations.